Mary Zanarini, EdD oversees an extensive research program at McLean Hospital in Belmont Massachusetts. Dr. Zanarini and her colleagues at McLean have followed, for 24 years, nearly 300 former inpatients with borderline personality disorder. Within that time half of the patients in the study achieved recovery, no longer meeting diagnostic criteria for borderline personality disorder as well as achieving good social and occupational functioning. This study has changed the view of BPD from a chronic disorder to the serious mental illness with the best symptomatic prognosis. Dr. Zanarini is also the principal investigator of an NIMH-funded, internet-based randomized controlled trial of an early form of treatment for BPD: psychoeducation. Results suggest that learning the latest information about BPD can reduce symptoms. Dr. Zanarini is also the author of McLean Screening Instrument for Borderline Personality Disorder.